Intravesical Epirubicin Versus Doxorubicin for Superficial Bladder Tumors (Stages pTa and pT1): a Randomized Prospective Study-Reference-Cited by-同舟云学术

Intravesical Epirubicin Versus Doxorubicin for Superficial Bladder Tumors (Stages pTa and pT1): a Randomized Prospective Study

Published:1997-07 Issue:1 Volume:158 Page:68-74
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Ali-El-Dein Bedeir¹,El-Baz Mahmoud¹,Aly Adel Nabeeh M.¹,Shamaa Sameh¹,Ashamallah Albair¹

Affiliation:

1. From the Departments of Pathology and Internal Medicine, and Urology and Nephrology Center, Faculty of Medicine, Mansoura University, Mansoura, Egypt.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. Herr, H. W. and Laudone, V. P.: Intravesical therapy for superficial bladder cancer. AUA Update Series, vol. VIII, lesson 12, 1989.

2. Shoukry, I.: Management of superficial bladder tumors. Bladder cancer symposium, NCl-ESO, Cairo, Egypt, November 2-4, 1988

3. The management of superficial bladder cancer.;Soloway;Cancer,1980

4. Rationale for intensive intravesical chemotherapy for superficial bladder cancer.;Soloway;J. Urol.,1980

5. Intravesical adriamycin chemotherapy in bladder cancer. Cancer Chemother;Matsumura;Pharmacol.,1983

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of short-term intravesical gemcitabine vs. long-term intravesical epirubicin in the treatment of moderate to high-risk non-muscle-invasive bladder cancer: a pilot study;Holistic Integrative Oncology;2024-02-20

2. Uncovering the epidemiology of bladder cancer in the Arab world: A review of risk factors, molecular mechanisms, and clinical features;Asian Journal of Urology;2023-10

3. Side Effects of Intravesical BCG and Chemotherapy for Bladder Cancer: What They Are and How to Manage Them;Urology;2021-03

4. Outcomes and complications of Hyperthermic IntraVesical Chemotherapy using Mitomycin-C or Epirubicin for patients with non-muscle invasive bladder cancer after Bacillus Calmette-Guérin treatment failure;Central European Journal of Urology;2020

5. The value of immediate postoperative intravesical epirubicin instillation as an adjunct to standard adjuvant treatment in intermediate and high-risk non–muscle-invasive bladder cancer: A preliminary results of randomized controlled trial;Urologic Oncology: Seminars and Original Investigations;2019-03